NVCT short interest
Nuvectis Pharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,522,106 |
|---|---|
| Change vs prior report | 159,579 (+6.8%) |
| Change over six months | +60.0% |
| Days to cover | 10.34 (sector: 3.78) |
| Average daily volume | 243,827 |
| Rank in Healthcare | #104 of 922 by days to cover |
NVCT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,522,106 | +6.8% | 10.34 | 243,827 |
| 2026-09-15 | 2,362,527 | +7.6% | 14.77 | 159,989 |
| 2026-08-31 | 2,196,224 | +19.6% | 9.33 | 235,465 |
| 2026-08-14 | 1,836,385 | -0.4% | 9.15 | 200,616 |
| 2026-07-31 | 1,843,596 | +21.9% | 7.40 | 249,062 |
| 2026-07-15 | 1,512,192 | -16.1% | 4.00 | 377,728 |
| 2026-06-30 | 1,802,732 | +14.9% | 2.29 | 788,911 |
| 2026-06-15 | 1,568,991 | -0.8% | 22.63 | 69,334 |
| 2026-05-29 | 1,580,880 | +10.8% | 13.62 | 116,044 |
| 2026-05-15 | 1,426,480 | -2.6% | 10.95 | 130,238 |
| 2026-04-30 | 1,464,074 | -5.0% | 29.81 | 49,114 |
| 2026-04-15 | 1,541,168 | -2.2% | 31.30 | 49,240 |
| 2026-03-31 | 1,575,869 | -2.7% | 23.00 | 68,516 |
| 2026-03-13 | 1,619,688 | -0.0% | 30.13 | 53,750 |
| 2026-02-27 | 1,620,407 | -1.5% | 44.32 | 36,560 |
| 2026-02-13 | 1,645,122 | +3.2% | 23.43 | 70,201 |
| 2026-01-30 | 1,593,652 | -1.4% | 27.71 | 57,505 |
| 2026-01-15 | 1,615,597 | +5.4% | 18.10 | 89,249 |
| 2025-12-31 | 1,532,728 | +7.2% | 19.61 | 78,146 |
| 2025-12-15 | 1,430,312 | +4.1% | 13.93 | 102,683 |
| 2025-11-28 | 1,374,419 | +3.6% | 16.87 | 81,449 |
| 2025-11-14 | 1,325,985 | +7.9% | 14.28 | 92,857 |
| 2025-10-31 | 1,229,398 | +36.5% | 9.14 | 134,521 |
| 2025-10-15 | 900,775 | -8.8% | 13.20 | 68,221 |
| 2025-09-30 | 987,672 | +15.6% | 9.28 | 106,425 |
import finzdata as yf
yf.Ticker("NVCT").short_interest # every report since 2017
yf.Client().short_interest(["NVCT"], start="2018-01-01")Healthcare short interest · NVCT price history · Who owns NVCT · All short interest